Eribulin Mesylate

Drug Index

Eribulin, sold under the brand name Halaven, is an anticancer medication used to treat breast cancer and liposarcoma.[2][4] The most common side effects include fatigue, nausea, hair loss (alopecia), constipation, certain nerve damage causing weakness or numbness in the hands and feet (peripheral neuropathy), abdominal pain and fever (pyrexia).[7] Eribulin may also cause low levels of infection-fighting white blood cells (neutropenia) or decreas...

NDC Database

Halaven .5 mg/ml Intravenous Injection by Eisai Inc. ## Package Codes: 62856-389-01 ## Active Ingredients: Eribulin Mesylate

NDC Database

Halaven .5 mg/ml Intravenous Injection by Bsp Pharmaceuticals Spa ## Package Codes: 43624-002-01 ## Active Ingredients: Eribulin Mesylate